Rizk Tarek
Known title: Chief Performance OfficerCIK: 0002059908
Associated companies
Transaction History
| SLB | ▲ Buy | Grant | 3,557 | $0 | 3/7/2025 | View on chart |
| SLB | ▲ Buy | Grant | 3,557 | $0 | 3/7/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
SLB Q3 Earnings Preview: Barclays Lowers Price Target to $66
SLB is preparing for its Q3 earnings release, with analysts expecting a decline in results. Barclays recently maintained an Overweight rating but lowered its price target to $66. This move comes as the stock trades near its 52-week low, reflecting broader market caution and sector-specific pressures.
SLB Q3 Earnings Preview: Barclays Lowers Price Target to $66. SLB is preparing for its Q3 earnings release, with analysts expecting a decline in results. Barclays recently maintained an Overweight rating but lowered its price target to $66. This move comes as the stock trades near its 52-week low, reflecting broader market caution and sector-specific pressures.